Trial Profile
The virology and clinical effects of peramivir on influenza virus infections in high-risk patients or patients with severe symptoms:an open-label, non-randomized, multi-centre study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2013
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacogenomic; Therapeutic Use
- 30 Jun 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 20 Jan 2013 Status changed from completed to recruiting as reported by University Hospital Medical Information Network - Japan.
- 20 Sep 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.